Mood Disorders in the News
The latest in mood disorder news, all in one place.
Stay updated with breaking news from Icahn School. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The latest in mood disorder news, all in one place.
Already approved for ulcerative colitis, the monoclonal antibody mirikizumab met study endpoints for Crohn's disease response and remission.
An unexpected idea gains traction and may provide clues about long COVID
Researchers at the Icahn School of Medicine at Mount Sinai have designed a regenerative medicine therapy to speed up diabetic wound repair. Using tiny fat
Researchers at the Icahn School of Medicine at Mount Sinai have designed a regenerative medicine therapy to speed up diabetic wound repair. Using tiny fat particles loaded with genetic instructions to calm down inflammation, the treatment was shown to target problem-causing cells and reduce swelling and harmful molecules in mouse models of damaged skin.